Breaking News

Chime Biologics Supports COVID-19 Outbreak in Wuhan

China-based CDMO launches stand-alone operations

By: Contract Pharma

Contract Pharma Staff

Chime Biologics, a China-based contract development and manufacturing organization (CDMO) providing fully-integrated services to support development and manufacturing of complex biologics, has begun operations as an independent and stand-alone biologics CDMO company. With the separation from JHL Biotech complete, Chime Biologics is now focused on delivering biologics CDMO services to its global clients and business partners.   “One year ago, we initiated a separation plan to realize a vision of ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters